Although research is being conducted on Long COVID or Long COVID-19, whose symptoms continue for weeks and months after initial infection, there are very few ongoing clinical trials on treatments. Anecdotally, there has been what appears to be a successful treatment for Long Covid using Pfizer’s antiviral regimen Paxlovid.
Multiple Studies Illustrate the Widespread Damage Wrought by COVID-19
ACS Chemical Neuroscience, Cell Metabolism, COVID-19 Studies, Fetus, Inflammation, Medical Journals, National Institutes of Health, Neuropilins, Pancreatic beta cells, Pregnancies, R&D, SARS-CoV-2 virus, Stanford University, T-Cells, Type 1 DiabetesAs a general rule, whatever health condition a person may have, COVID-19 makes it worse. But COVID-19 also causes certain conditions or is being implicated in their earlier onset. Type 1 diabetes and Parkinson’s disease are prime examples. Now, researchers report that the SARS-CoV-2 virus may also cause fetal inflammation, even when the placenta itself is not inflamed.
Don’t Count Out Omicron Sibling BA.2, and More COVID-19 News
BNT162b2 (Pfizer and BioNTech), Brain, Business, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, Covid Brain Fog, COVID-19 cases, COVID-19 Vaccines, Cytokines, Data, Delta Variant (B.1.617.2; India), Denmark, FDA, HIV, HIV Vaccines, Long COVID, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Omicron (B.1.1.529) (South Africa), Omicron BA.2, R&D, Researchers, Stanford University, The Bill and Melinda Gates Foundation, University of California, San FranciscoThe prevailing theory about the Omicron variant is that it is going to rip through the population quickly and possibly burn out, marking the downside of the COVID-19 pandemic. But researchers are expressing concern about a subvariant of Omicron dubbed BA.2 that appears to be tearing through Denmark, just as the first Omicron wave subsided.
A study published in Nature Communications reveals that patients who had been hospitalized with severe Covid-19 might not be totally safe after recovery, as they are more likely to harbor self-attacking antibodies than those who did not have the virus.
Coronavirus cases continued their grim climb in the United States with Midwestern states experiencing record hospitalizations, as increasingly bitter rhetoric kept the virus front and center of campaigning two days before the presidential election.
While the world waits for a vaccine against SARS-CoV-2 – the novel coronavirus that causes COVID-19 – one likely control and exit strategy is testing for immunity, or an antibody test.
Researchers developed a type of nanoparticle that can “eat debris” related to the plaques that cause heart attacks.
Allogene Therapeutics inked a research collaboration deal with Stanford University to work on a novel nucleic acid delivery system for CAR-T therapy.
Three U.S. senators introduced a resolution in support of a moratorium and other limits on gene editing embryos.